Thus, the mechanisms of action of JTD in the treatment of VD may be closely related to multiple pathways, including lipid and atherosclerosis, neurodegeneration in multiple diseases, calcium signaling, fluid shear stress and atherosclerosis, PI3K-Akt signaling, and MAPK signaling. This evidence concerns the gene AKT1 and atherosclerosis.